Urban Lundberg

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease.

Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease.

Journal: Vaccine
Published: September 02, 2025

Preclinical Evidence for the Protective Capacity of Antibodies Induced by Lyme Vaccine Candidate VLA15 in People.

Preclinical Evidence for the Protective Capacity of Antibodies Induced by Lyme Vaccine Candidate VLA15 in People.

Journal: Open forum infectious diseases
Published: May 21, 2024

Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.

Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.

Journal: Communications medicine
Published: May 22, 2023

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.

Journal: JCI insight
Published: April 15, 2022

Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.

Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.

Journal: Infection and immunity
Published: December 06, 2019

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial.

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial.

Journal: The Lancet. Infectious diseases
Published: October 01, 2019

Protective Immunity and New Vaccines for Lyme Disease.

Protective Immunity and New Vaccines for Lyme Disease.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 17, 2019

The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.

The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.

Journal: PloS one
Published: February 22, 2017

Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination.

Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination.

Journal: Allergy
Published: August 26, 2016

Heat-labile enterotoxin of Escherichia coli promotes intestinal colonization of Salmonella enterica.

Heat-labile enterotoxin of Escherichia coli promotes intestinal colonization of Salmonella enterica.

Journal: Comparative immunology, microbiology and infectious diseases
Published: March 25, 2015

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis.

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis.

Journal: Vaccine
Published: February 23, 2015

Complete genome sequence of Borrelia afzelii K78 and comparative genome analysis.

Complete genome sequence of Borrelia afzelii K78 and comparative genome analysis.

Journal: PloS one
Published: October 22, 2014
Showing 1-12 of 17

Last Updated: 09/26/2026